• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶活性与近端亚端粒处DNA甲基化增加以及端粒转录减少相关。

Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription.

作者信息

Ng Laura J, Cropley Jennifer E, Pickett Hilda A, Reddel Roger R, Suter Catherine M

机构信息

Victor Chang Cardiac Research Institute, Darlinghurst 2010, Australia.

出版信息

Nucleic Acids Res. 2009 Mar;37(4):1152-9. doi: 10.1093/nar/gkn1030. Epub 2009 Jan 7.

DOI:10.1093/nar/gkn1030
PMID:19129228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2651807/
Abstract

Tumours and immortalized cells avoid telomere attrition by using either the ribonucleoprotein enzyme telomerase or a recombination-based alternative lengthening of telomeres (ALT) mechanism. Available evidence from mice suggests that the epigenetic state of the telomere may influence the mechanism of telomere maintenance, but this has not been directly tested in human cancer. Here we investigated cytosine methylation directly adjacent to the telomere as a marker of the telomere's epigenetic state in a panel of human cell lines. We find that while ALT cells show highly heterogeneous patterns of subtelomeric methylation, subtelomeric regions in telomerase-positive cells invariably show denser methylation than normal cells, being almost completely methylated. When compared to matched normal and ALT cells, telomerase-positive cells also exhibit reduced levels of the telomeric repeat-containing-RNA (TERRA), whose transcription originates in the subtelomere. Our results are consistent with the notion that TERRA may inhibit telomerase: the heavy cytosine methylation we observe in telomerase-positive cells may reflect selection for TERRA silencing in order to facilitate telomerase activity at the telomere. These data suggest that the epigenetic differences between telomerase-positive and ALT cells may underlie the mechanism of telomere maintenance in human tumorigenesis and highlight the broad reaching consequences of epigenetic dysregulation in cancer.

摘要

肿瘤细胞和永生化细胞通过使用核糖核蛋白酶端粒酶或基于重组的端粒替代延长(ALT)机制来避免端粒磨损。来自小鼠的现有证据表明,端粒的表观遗传状态可能影响端粒维持机制,但这尚未在人类癌症中得到直接验证。在这里,我们研究了在一组人类细胞系中紧邻端粒的胞嘧啶甲基化,将其作为端粒表观遗传状态的标志物。我们发现,虽然ALT细胞显示出亚端粒甲基化的高度异质性模式,但端粒酶阳性细胞中的亚端粒区域总是比正常细胞显示出更密集的甲基化,几乎完全甲基化。与匹配的正常细胞和ALT细胞相比,端粒酶阳性细胞还表现出端粒重复序列含RNA(TERRA)水平的降低,其转录起始于亚端粒。我们的结果与TERRA可能抑制端粒酶的观点一致:我们在端粒酶阳性细胞中观察到的大量胞嘧啶甲基化可能反映了对TERRA沉默的选择,以便促进端粒处的端粒酶活性。这些数据表明,端粒酶阳性细胞和ALT细胞之间的表观遗传差异可能是人类肿瘤发生中端粒维持机制的基础,并突出了癌症中表观遗传失调的广泛影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/cdb7751c9dda/gkn1030f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/e469d3663560/gkn1030f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/d1e8061b7afd/gkn1030f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/69cf758eb65c/gkn1030f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/cdb7751c9dda/gkn1030f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/e469d3663560/gkn1030f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/d1e8061b7afd/gkn1030f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/69cf758eb65c/gkn1030f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e5/2651807/cdb7751c9dda/gkn1030f4.jpg

相似文献

1
Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription.端粒酶活性与近端亚端粒处DNA甲基化增加以及端粒转录减少相关。
Nucleic Acids Res. 2009 Mar;37(4):1152-9. doi: 10.1093/nar/gkn1030. Epub 2009 Jan 7.
2
DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.DNA甲基化介导的TERRA非编码RNA上调与人胎盘端粒延长同时发生。
Mol Hum Reprod. 2016 Nov;22(11):791-799. doi: 10.1093/molehr/gaw053. Epub 2016 Sep 7.
3
Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells.低甲基化药物可有效降低端粒 DNA 中的胞嘧啶甲基化,并激活端粒酶,而不影响烟草细胞中端粒的长度。
Plant Mol Biol. 2011 Nov;77(4-5):371-80. doi: 10.1007/s11103-011-9816-7. Epub 2011 Aug 25.
4
Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway.人类亚端粒的表观遗传特征在利用端粒替代延长(ALT)途径的细胞中存在差异。
Life (Basel). 2021 Mar 26;11(4):278. doi: 10.3390/life11040278.
5
Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.端粒外延长(ALT)细胞中端粒和亚端粒的单分子分析。
BMC Genomics. 2020 Jul 15;21(1):485. doi: 10.1186/s12864-020-06901-7.
6
Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.端粒替代延长细胞中端粒酶基因表达的缺失与hTR和hTERT基因启动子的染色质重塑相关。
Cancer Res. 2005 Sep 1;65(17):7585-90. doi: 10.1158/0008-5472.CAN-05-1715.
7
Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.端粒酶活性重建对通过端粒替代延长(ALT)途径进行端粒维持的影响。
Hum Mol Genet. 2001 Sep 1;10(18):1953-61. doi: 10.1093/hmg/10.18.1953.
8
Telomerase efficiently elongates highly transcribing telomeres in human cancer cells.端粒酶能有效地延长人类癌细胞中高转录的端粒。
PLoS One. 2012;7(4):e35714. doi: 10.1371/journal.pone.0035714. Epub 2012 Apr 27.
9
DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.人端粒酶逆转录酶(hTERT)基因的DNA甲基化谱与胃腺癌中端粒的表现
J Gastrointest Cancer. 2020 Sep;51(3):788-799. doi: 10.1007/s12029-020-00427-7.
10
Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?端粒的替代延长(ALT)与染色质:它们之间有关联吗?
Biochimie. 2008 Jan;90(1):5-12. doi: 10.1016/j.biochi.2007.08.009. Epub 2007 Sep 2.

引用本文的文献

1
A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.一种用于发现端粒替代延长(ALT)途径调节剂的首创高通量筛选方法。
ACS Pharmacol Transl Sci. 2024 Aug 13;7(9):2799-2819. doi: 10.1021/acsptsci.4c00251. eCollection 2024 Sep 13.
2
Hydration water drives the self-assembly of guanosine monophosphate.水合水驱动单磷酸鸟苷的自组装。
Biophys J. 2024 Apr 16;123(8):931-939. doi: 10.1016/j.bpj.2024.03.005. Epub 2024 Mar 7.
3
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the and Genes.

本文引用的文献

1
Epigenetic regulation of telomeres in human cancer.人类癌症中端粒的表观遗传调控。
Oncogene. 2008 Nov 20;27(54):6817-33. doi: 10.1038/onc.2008.289. Epub 2008 Sep 1.
2
Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions.ICF综合征中染色体亚端粒区域的低甲基化与异常短的端粒及端粒区域转录增强相关。
Hum Mol Genet. 2008 Sep 15;17(18):2776-89. doi: 10.1093/hmg/ddn177. Epub 2008 Jun 16.
3
Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II.
一组高危神经母细胞瘤肿瘤中的端粒维持机制及其与 和 基因中基因组变异的关系。
Cancers (Basel). 2023 Dec 7;15(24):5732. doi: 10.3390/cancers15245732.
4
The RNA-binding motif protein 14 regulates telomere integrity at the interface of TERRA and telomeric R-loops.RNA 结合基序蛋白 14 在端粒重复序列 RNA(TERRA)和端粒 R 环的界面处调节端粒的完整性。
Nucleic Acids Res. 2023 Dec 11;51(22):12242-12260. doi: 10.1093/nar/gkad967.
5
R-Loops at Chromosome Ends: From Formation, Regulation, and Cellular Consequence.染色体末端的R环:从形成、调控到细胞后果
Cancers (Basel). 2023 Apr 6;15(7):2178. doi: 10.3390/cancers15072178.
6
Telomere Transcription in -Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy.重排白血病细胞系中的端粒转录:TERRA水平升高与淋巴谱系相关,且独立于端粒长度和倍性。
Biomedicines. 2023 Mar 16;11(3):925. doi: 10.3390/biomedicines11030925.
7
Mammalian telomeric RNA (TERRA) can be translated to produce valine-arginine and glycine-leucine dipeptide repeat proteins.哺乳动物端粒 RNA(TERRA)可以被翻译以产生缬氨酸-精氨酸和甘氨酸-亮氨酸二肽重复蛋白。
Proc Natl Acad Sci U S A. 2023 Feb 28;120(9):e2221529120. doi: 10.1073/pnas.2221529120. Epub 2023 Feb 22.
8
Telomeres susceptibility to environmental arsenic exposure: Shortening or lengthening?端粒对环境砷暴露的敏感性:缩短还是延长?
Front Public Health. 2023 Jan 10;10:1059248. doi: 10.3389/fpubh.2022.1059248. eCollection 2022.
9
TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer.端粒重复序列RNA(TERRA):生理功能及其在癌症中的相关性
Front Oncol. 2022 Aug 2;12:913314. doi: 10.3389/fonc.2022.913314. eCollection 2022.
10
DNA-RNA hybrid G-quadruplex tends to form near the 3' end of telomere overhang.DNA-RNA 杂合 G-四链体倾向于在端粒突出的 3' 末端附近形成。
Biophys J. 2022 Aug 2;121(15):2962-2980. doi: 10.1016/j.bpj.2022.06.026. Epub 2022 Jun 28.
由DNA依赖性RNA聚合酶II对哺乳动物端粒进行的发育调控转录。
Nat Cell Biol. 2008 Feb;10(2):228-36. doi: 10.1038/ncb1685. Epub 2007 Dec 23.
4
Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends.哺乳动物染色体末端含端粒重复序列的RNA及RNA监测因子。
Science. 2007 Nov 2;318(5851):798-801. doi: 10.1126/science.1147182. Epub 2007 Oct 4.
5
Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression.孕期胆碱缺乏通过上调Dnmt1表达导致整体及Igf2基因DNA高甲基化。
J Biol Chem. 2007 Oct 26;282(43):31777-88. doi: 10.1074/jbc.M705539200. Epub 2007 Aug 27.
6
Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres.端粒长度调节哺乳动物端粒和亚端粒的表观遗传状态。
Nat Genet. 2007 Feb;39(2):243-50. doi: 10.1038/ng1952. Epub 2007 Jan 21.
7
Heterochromatin revisited.异染色质再探讨。
Nat Rev Genet. 2007 Jan;8(1):35-46. doi: 10.1038/nrg2008.
8
Cancer-linked DNA hypomethylation and its relationship to hypermethylation.癌症相关的DNA低甲基化及其与高甲基化的关系。
Curr Top Microbiol Immunol. 2006;310:251-74. doi: 10.1007/3-540-31181-5_12.
9
DNA methyltransferases control telomere length and telomere recombination in mammalian cells.DNA甲基转移酶控制哺乳动物细胞中的端粒长度和端粒重组。
Nat Cell Biol. 2006 Apr;8(4):416-24. doi: 10.1038/ncb1386. Epub 2006 Mar 26.
10
Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops.端粒酶替代途径(ALT)细胞中的端粒DNA以游离端粒环和异质性t环为特征。
Mol Cell Biol. 2004 Nov;24(22):9948-57. doi: 10.1128/MCB.24.22.9948-9957.2004.